Novadaq Technologies Inc.
TSX : NDQ

Novadaq Technologies Inc.

November 03, 2005 09:00 ET

Novadaq to Hold Third Quarter 2005 Conference Call and Webcast

TORONTO, ONTARIO--(Marketwire - Nov. 3, 2005) - Novadaq® Technologies Inc. (TSX:NDQ) today announced that it intends to host a conference call on Thursday, November 10, 2005 at 10:00 a.m. E.T. to discuss its financial results for the third quarter ended September 30, 2005. The Company intends to disclose its financial results via news release on November 9, 2005 at market close.

To access the conference call by telephone, dial 1-800-814-4890 or 416-644-3427. Please connect approximately ten minutes prior to the beginning of the call to ensure participation. The conference call will be archived for replay until November 17, 2005 at midnight. To access the archived conference call, dial 416-640-1917 or 1-877-289-8525 enter the reservation number 21160122 followed by the number sign.

A live audio webcast of the conference call will be available at www.novadaq.com. Please connect at least ten minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived at the above website for 90 days.

About Novadaq Technologies

Novadaq Technologies (TSX:NDQ) develops and commercializes medical devices based on its proprietary imaging platform for the diagnosis and treatment of human vascular and ophthalmic diseases and conditions. Novadaq's SPY Intra-operative Imaging System enables surgeons to visually assess coronary vasculature and bypass graft functionality during the course of cardiac surgery. Novadaq's ophthalmic product, the OPTTX™ System, is aimed at the diagnosis, evaluation and treatment of wet Age-related Macular Degeneration (AMD) by using the same core imaging technology that is used in the SPY System. The OPTTX System is currently being evaluated in clinical trials.

For more information, please visit the company's website at www.novadaq.com.

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Novadaq's current beliefs as well as assumptions made by and information currently available to Novadaq and relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Novadaq in its public securities filings, actual events may differ materially from current expectations. Novadaq disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Contact Information